Name | Clindamycin Hydrochloride Monohydrate |
---|---|
Synonyms |
Methyl (5R)-5-[(1S,2S)-2-chloro-1-{[(4R)-1-methyl-4-propyl-L-prolyl]amino}propyl]-1-thio-β-L-arabinopyranoside hydrochloride hydrate
clindamycin hydrochloride hydrate L-threo-α-D-galacto-Octopyranoside, methyl 7-chloro-6,7,8-trideoxy-6-[[[(2S,4R)-1-methyl-4-propyl-2-pyrrolidinyl]carbonyl]amino]-1-thio-, hydrochloride, hydrate (1:1:1) |
Description | Clindamycin hydrochloride monohydrate is an oral protein synthesis inhibitory agent that has the ability to suppress the expression of virulence factors in Staphylococcus aureus at sub-inhibitory concentrations (sub-MICs). Clindamycin hydrochloride monohydrate resistance results from enzymatic methylation of the antibiotic binding site in the 50S ribosomal subunit (23S rRNA). Clindamycin hydrochloride monohydrate decreases the production of Panton-Valentine leucocidin (PVL), toxic-shock-staphylococcal toxin (TSST-1) or alpha-haemolysin (Hla)[1]. |
---|---|
Related Catalog | |
References |
Boiling Point | 647ºC at 760 mmHg |
---|---|
Melting Point | 143ºC |
Molecular Formula | C18H36Cl2N2O6S |
Molecular Weight | 479.459 |
Flash Point | 345.1ºC |
Exact Mass | 478.167114 |
PSA | 136.79000 |
LogP | 1.45600 |
Index of Refraction | 143 ° (C=2, H2O) |
Water Solubility | Soluble in water |
Hazard Codes | Xi: Irritant; |
---|---|
Risk Phrases | 36/37/38 |
Safety Phrases | 26-37/39 |
RIDADR | NONH for all modes of transport |
RTECS | GF2275000 |
HS Code | 29419090 |